Get started
Author

Maria Luisa Meacci

Observed names: M L Meacci, M Meacci, M. Meacci, M.L Meacci, M.L. Meacci, Maria L. Meacci
OpenAlex ID: A5111938372
Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer
1998 · V Minotti, L Crino′, et al. · Lung Cancer · 81
A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group
1990 · Lucio Crino, Maurizio Tonato, et al. · Cancer Chemotherapy and Pharmacology · 50
Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer
1993 · L. Crinò, P. Latini, et al. · Annals of Oncology · 46
PDF
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva
2020 · Michele Bartoletti, Roberta Mazzeo, et al. · International Journal of Gynecological Cancer · 35
PDF
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation
2011 · Giulio Metro, R. Chiari, et al. · Cancer Chemotherapy and Pharmacology · 20
Treatment of advanced non-small cell lung cancer (NSCLC): The ‘Umbria’ cooperative study
1989 · L Crinó, S Darwish, et al. · Lung Cancer · 14
Long term results in locally advanced inoperable Non Small Cell Lung Cancer (NSCLC): A randomised trial of induction chemotherapy (CT) plus radiotherapy (RT) vs radiation alone
1991 · L. Crinò, M. Meacci, et al. · Lung Cancer · 13
Cisplatin (CDDP)-etoposide VS DCCP-mitomycin-vindesine VS CDDP-mitomycin-iphosphamide in advanced non small cell lung cancer (NSCLC). A prospective randomized trial of the Italian oncology group for clinical research. (GOIRC)
1993 · L. Crinò, M. Clerici, et al. · European Journal of Cancer · 12
Carboplatin (CBDOA) plus etoposide (VP16) and vicristine (VCR) in treatment of Small Cell Lung Cancer (SCLC)
1991 · L. Crinò, F. De Marinis, et al. · Lung Cancer · 10
Oral anticancer therapy project: Clinical utility of a specific home care nursing programme on behalf of Italian Association of Medical Oncology (AIOM)
2019 · Massimo Cirillo, Luciano Carlucci, et al. · Journal of Clinical Nursing · 5
Intensification with high-dose (HD) chemotherapy and concurrent b.i.d. radiotherapy in limited (LD) small cell lung cancer (SCLC). Preliminary results of a phase II trial
1994 · L. Crinò, F. De Marinis, et al. · Lung Cancer · 4
176 Combination chemotherapy with cisplatin and teniposide (VM26) or etoposide (VP16) for brain metastasis of small cell lung cancer (SCLC): A phase II study
1997 · L. Crinò, M.A. Palladino, et al. · Lung Cancer · 2
73 Chemotherapy with cisplatin and teniposide (VM26) for cerebral metastasis in non small cell lung cancer (NSCLC): A phase II study
1997 · V. Minotti, L. Crino, et al. · Lung Cancer · 1
Alk and Ros1-Positive Lung Adenocarcinoma (La) Patient Outcomes: a Mono-Istitutional Experience
2014 · R. Chiari, G. Metro, et al. · Annals of Oncology
Clinical Features and Outcome in Never-Smoker (Ns) Non-Small Cell Lung Cancer (Nsclc) Patients (Pts): a Single-Institution Observational Analysis
2014 · C. Bennati, R. Chiari, et al. · Annals of Oncology
A new PRKAR1A gene mutation in the carney complex syndrome: A case report
2012 · M. Boncompagni, R. Ciaccarini, et al. · European Journal of Surgical Oncology
9081 A phase II retrospective trial of Carboplatin (CBDCA) and Alimta in refractory non-small cell lung cancer (NSCLC) with genetic polymorphisms analysis
2009 · V. Ludovini, L. Pistola, et al. · European Journal of Cancer Supplements
9046 A phase II retrospective trial of Platinum/Gemcitabine (P/G)-based in first line treatment of advanced NSCLC with genetic polymorphisms analysis
2009 · M. Meacci, V. Ludovini, et al. · European Journal of Cancer Supplements
Effect of genetic polymorphisms on toxicity and survival in advanced non-small cell lung cancer (NSCLC) patients (pts) treated with carboplatin (CBDCA) and pemetrexed disodium regimen
2009 · V. Ludovini, L. Crinò, et al. · Journal of Clinical Oncology
Correlation of polymorphisms of genes involved in platinum/gemcitabine (P/G)-based metabolism with toxicity and clinical response in patients (pts) with advanced non-small cell lung cancer (NSCLC)
2009 · M. Tonato, V. Ludovini, et al. · Journal of Clinical Oncology
128pd Egfr, Kras, Pik3ca Mutations and Response to Tyrosine Kinase Inhibitors (tkis) in Advanced Nsclc Patients
2009 · L. Crinò, L. Pistola, et al. · Lung Cancer
[The difficult choice: when not to treat. Advanced stomach cancer].
2004 · Maria Luisa Meacci, Maria Pia Rosito · PubMed
Induction chemotherapy followed by intensification with high-dose (H.D.) chemotherapy in extensive small cell lung cancer (SCLC) — Preliminary results of a phase II trial
1994 · M. Meacci, L. Crinò, et al. · Lung Cancer
Do Italian small cell lung cancer (SCLC) specialists share a common language? An analysis based on 549 questionnaires.
1994 · G Rosti, M Meacci, et al. · PubMed
Italian clinical experience from the major co-operative groups in small cell lung cancer.
1994 · L Crinò, M Meacci, et al. · PubMed
Works count: 27
Citation count: 293
H-index: 9
I10-index: 9
Year
Topic
Type